VideoHIVHIV DART and Emerging Viruses 2018Hispanic/Latino longitudinal cohort of HIV-seropositive women and neurological complications | Loyda Melendez, PhDView Video
VideoRSVHIV DART and Emerging Viruses 2018Zika and other emerging viruses in the Americas | Mehul SutharView Video
VideoHIVHIV DART and Emerging Viruses 2018Gertrude Elion Distinguished Lecturer Award Lecture: Innovation with an Impact: Development of HIV and TB drugs | Paul Stoffels, MDView Video
VideoHIVHIV DART and Emerging Viruses 2018HIV reservoir dynamics: Implications for HIV latency establishment and reversal | Deanna Kulpa, PhDView Video
VideoHIVHIV DART and Emerging Viruses 2018State of the Art Lecture: Molecular basis for HIV latency | Jonathan Karn, PhDView Video
VideoHIVHIV DART and Emerging Viruses 2018Understanding barriers to HIV cure | Robert Siliciano, MD, PhDView Video
VideoHIVHIV DART and Emerging Viruses 2018Baricitinib reverses HIV associated neurocognitive disorders and reservoir seeding in a SCID mouse model | Christina Gavegnano, PhDView Video
SDSteven DeeksMDVideoHIVHIV DART and Emerging Viruses 2018State of the Art Lecture: Harnessing the immune system to eliminate and/or control HIV | Steven Deeks, MDView Video
BCBonaventura ClotetMD, PhDVideoHIVHIV DART and Emerging Viruses 2018Barry-Wainberg DART Achievement Award Lecture: Overview of the research conducted at the Irsicaixa Foundation | Bonaventura Clotet, MD, PhDView Video
VideoOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018Targeted agents and monoclonal antibodies | Joseph Ciccolini, PharmD, PhDView Video
VideoOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018Cytotoxic agents | Markus Jörger, MD, PhDView Video
HGHoward GurneyMBBS, FRACPVideoOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018Rationale for selecting combinations with immunotherapy | Howard Gurney, MBBS, FRACPView Video
